Screener
HEAL vs GNOM
Global X HealthTech ETF vs Global X Genomics & Biotechnology ETF
Key differences
- Over the last 3 years, GNOM has delivered higher annualized returns.
Side-by-side comparison
| HEAL | GNOM | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.50% |
| Fund size (AUM) | $25M | $51M |
| Since | 2020 | 2019 |
| Dividend yield | 0.38% | 1.38% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | -20.2% | +53.6% |
| CAGR 3Y | -10.3% | -2.6% |
| CAGR 5Y | -14.0% | -10.5% |
| Sharpe 3Y | -0.46 | -0.06 |
| Volatility 1Y | 21.71% | 26.15% |
| Max drawdown | -65.76% | -75.00% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to HEAL and GNOM
Explore further